Ark Invest Shifted Holdings in Latest Trade Round

The asset manager adjusted positions in space and technology stocks, impacting several of its popular exchange-traded funds.

Updated on Sept. 23, 2026 in Investing

Bold flat-color editorial illustration of a metallic module and glass vial, representing institutional technology and aerospace sector asset management.
Ark Invest rebalanced its portfolio this week, adjusting holdings in aerospace and technology stocks across several of its exchange-traded funds. AI Illustration. Upload story photo >

Live Poll

Do you trust the investment strategies led by high-profile fund managers like Cathie Wood?

Ark Invest recently executed a series of trades across its exchange-traded funds, including the purchase of Rocket Lab shares and the sale of Alphabet stock. These movements reflect ongoing portfolio rebalancing by the investment firm.

Why it matters

Portfolio adjustments by major managers can signal shifts in sector sentiment, though individual investors should note that these moves do not account for personal risk tolerance. Decisions to alter holdings often follow changing market dynamics, such as the competitive environment between search providers.

Ark Invest added 369,612 shares of Rocket Lab across its ARKK, ARKQ, ARKX, and ARKG funds, while simultaneously offloading 16,422 Class A shares of Alphabet. The trades follow a period where Alphabet previously lost search share to OpenAI in 2025.

The players

Ark Invest

An asset management firm that offers various exchange-traded funds focused on disruptive innovation and technology.

Rocket Lab

An aerospace company that provides launch services and has completed 96 successful Electron launches to date.

Alphabet

The parent company of Google, which provides search and advertising services that influence broad market benchmarks.

The details

Ark Invest utilized four of its exchange-traded funds to recalibrate exposure to various technology and aerospace companies. The firm also sold 21,335 shares of Twist Bioscience and 49,651 shares of 10x Genomics while acquiring 9,519 shares of Beam Therapeutics and 12,583 shares of Veracyte. These trades are part of the firm's standard portfolio management process, which influences the underlying holdings of investors who own shares in these specific funds.

Timeline

  1. 2025 marked the period when Alphabet faced increased competition from OpenAI.

  2. September 22, 2026, was the date Ark Invest executed the trades.

  3. Late 2026 is the targeted timeframe for the first launch of the Neutron rocket.

  4. Mid-2027 is the expected closing date for the Iridium Communications acquisition.

Money Landscape

This activity occurs within a broader cycle of rebalancing as managers respond to shifts in the search engine market that emerged in 2025. Investors are observing how these firms adjust their exposure to high-growth sectors versus established large-cap technology.

If you hold any of the Ark exchange-traded funds mentioned, your indirect exposure to Rocket Lab and Alphabet has shifted. Review your fund prospectuses or consult with a qualified financial professional to ensure your current asset allocation still aligns with your long-term goals.

The takeaway

Large-scale asset managers frequently rotate positions to capture growth or manage risk across their funds. Investors should monitor fund holdings periodically to ensure the underlying assets still match their personal risk and return requirements.

What happens next

Rocket Lab plans to launch its Neutron rocket in late 2026 and expects to close the Iridium Communications acquisition in mid-2027.

Further reading

For more on managing a portfolio, see our section on Investing.

Live Poll

Do you trust the investment strategies led by high-profile fund managers like Cathie Wood?